Abstract:Schematic overview of VDAC1+/+ and VDAC1+/− model: Working model for the regulation of mitophagy, mitochondrial dynamics, mitochondrial biogenesis, VDAC1, and Hexokinase interaction, and VDAC1 and P‐Tau interaction. In VDAC1+/+, (i) dissociation of hexokinase (HK) results in a "closed" VDAC configuration that prevents adenine nucleotide exchange and uncouples intra and extramitochondrial metabolism, (ii) shifts the equilibrium to the VDAC1 oligomeric state, mediating the release of apoptogenic proteins and leading to apoptosis, (iii) Elevated GSK3β activity is a key event in phosphorylation of Tau and synaptic pathology in AD. GSK3β is proposed to activate VDAC1 phosphorylation, ultimately leading to mitochondrial dysfunction and synaptic damage in AD, (iv) Defective mitophagy, (v) increased mitochondrial fission and decreased mitochondrial fusion. In VDAC1+/− (i) VDAC1 and ANT reportedly interact directly when complexed with HK, an arrangement that facilitates mitochondrial contact site formation and metabolite exchange, (ii) decreased GSK3β and P‐Tau activity, and (iii) PINK1 recruits PARKIN from the cytoplasm to mitochondrial outer membrane. After PARKIN has been recruited to mitochondria, activated PARKIN ubiquitinates proteins in the mitochondrial outer membrane VDAC to facilitate mitophagy. PARKIN‐mediated ubiquitination recruits autophagy adapter protein p62, and these proteins interact with LC3B. LC3B participates in the formation of an autophagosome, which is fated for lysosomal destruction to clear out damaged mitochondrion, (iv) decreased mitochondrial fission and increased mitochondrial fusion. Alzheimer's disease (AD) is the most common cause of mental dementia in the aged population. AD is characterized by the progressive decline of memory and multiple cognitive functions, and changes in behavior and personality. Recent research has revealed age‐dependent increased levels of VDAC1 in postmortem AD brains and cerebral cortices of APP, APPxPS1, and 3xAD.Tg mice. Further, we found abnormal interaction between VDAC1 and P‐Tau in the AD brains, leading to mitochondrial structural and functional defects. Our current study aimed to understand the impact of a partial reduction of voltage‐dependent anion channel 1 (VDAC1) protein on mitophagy/autophagy, mitochondrial and synaptic activities, and behavior changes in transgenic TAU mice in Alzheimer's disease. To determine if a partial reduction of VDAC1 reduces mitochondrial and synaptic toxicities in transgenic Tau (P301L) mice, we crossed heterozygote VDAC1 knockout (VDAC1+/−) mice with TAU mice and generated double mutant (VDAC1+/−/TAU) mice. We assessed phenotypic behavior, protein levels of mitophagy, autophagy, synaptic, other key proteins, mitochondrial morphology, and dendritic spines in TAU mice relative to double mutant mice. Partial reduction of VDAC1 rescued the TAU‐induced behavioral impairments such as motor coordination and exploratory behavioral changes, and learning and spatial memory impairments in VDAC1+/−/TAU mice. Protein levels of mitophagy, autophagy, and synaptic proteins were significantly increased in double mutant mice compared with TAU mice. In addition, dendritic spines were significantly increased; the mitochondrial number was significantly reduced, and mitochondrial length was increased in double mutant mice. Based on these observations, we conclude that reduced VDAC1 is beneficial in symptomatic‐transgenic TAU mice.

Inhibition of VDAC1 Rescues Aβ1-42-Induced Mitochondrial Dysfunction and Ferroptosis via Activation of AMPK and Wnt/β-Catenin Pathways

Changes In Mitochondrial Dynamics During Amyloid Beta-Induced Pc12 Cell Apoptosis

Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer's disease

Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology

Amyloid beta glycation leads to neuronal mitochondrial dysfunction and Alzheimers pathogenesis through VDAC1-dependent mtDNA efflux

Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood-brain barrier destruction in Alzheimer's disease

A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model

Vitamin D Attenuates Alzheimer-like Pathology Induced by Okadaic Acid

Study of mitophagy and ATP-related metabolomics based on β-amyloid levels in Alzheimer's disease

The involvement of lidocaine in amyloid-β1-42-dependent mitochondrial dysfunction and apoptosis in hippocampal neurons via nerve growth factor-protein kinase B pathway

Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer’s disease via inhibition of ACSL4-dependent ferroptosis

Mitochondrial Aldehyde Dehydrogenase (ALDH2) Rescues Cardiac Contractile Dysfunction in an APP/PS1 Murine Model of Alzheimer's Disease Via Inhibition of ACSL4-dependent Ferroptosis.

Mitochondrial Toxic Effects of Aβ Through Mitofusins in the Early Pathogenesis of Alzheimer’s Disease

Activation of vitamin D receptor inhibits Tau phosphorylation is associated with reduction of iron accumulation in APP/PS1 transgenic mice

Ganoderic acid a decreased Aβ42-induced neurotoxicity in PC12 cells by reduced mitochondrial damage

The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer's disease

Amyloid Β-Induced Impairments in Hippocampal Synaptic Plasticity Are Rescued by Decreasing Mitochondrial Superoxide

IRE1α-XBP1 Affects the Mitochondrial Function of Aβ25–35-Treated SH-SY5Y Cells by Regulating Mitochondria-Associated Endoplasmic Reticulum Membranes

Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease